drugset / Press release
Akcea and Ionis Receive FDA Approval of TEGSEDI™ (inotersen) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
2018-10-05 · Ionis Pharmaceuticals · original ionis.com ↗
TEGSEDI provides powerful knockdown of TTR protein, delivering significant and sustained benefits in neuropathy and quality of life
The release as fetched from its publisher. ionis.com ↗